शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

BSENOVYRA PHARMACHEM LIMITED· Agricultural Food & other ProductsHighNeutral
Announced Mon, 2 Nov, 2026 · 17:43 IST

Standalone Sep 2026 revenue jumps to Rs423.08 lakh; profit turns to loss

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

For the standalone quarter ended Sep 30, 2026, revenue from operations was Rs423.08 lakh versus nil in Sep 30, 2025; total revenue was Rs426.78 lakh versus Rs3.31 lakh. Profit after tax was a Rs3.33 lakh loss versus a Rs0.10 lakh profit. Standalone half-year revenue was Rs599.39 lakh and profit after tax was a Rs5.31 lakh loss. Half-year operating cash flow was positive at Rs49.84 lakh. Comparatives were regrouped or reclassified.

Likely market impact

Revenue growth and positive operating cash flow support sentiment, but continued losses may weigh on the stock and valuation.

By the numbersStandalone · Q2 FY27

The company's XBRL figures for this quarter look filed in the wrong unit: revenue reads ₹4.23 Cr against ₹0.03 Cr a year ago, about 128× larger. A move that size is almost always a wrong unit, not a business, so nothing is computed from these figures and no number-based tags are set; the read above is the AI's, from the document.